叶酸受体α-一种新的癌症治疗方法
Teresita Gonzalez1, Meri Muminovic1, Olger Nano1
1Memorial Cancer Institute, Pembroke Pines, FL 33028, USA.
International journal of molecular sciences
|January 23, 2024
概括
叶酸受体α (FRα) 在癌细胞中过度表达,使其成为新的癌症疗法的关键标. 它在瘤生长中的作用以及它在各种癌症中的存在凸显了它在精准医学中的重要性.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 叶酸受体α (FRα) 是一种由FOLR1基因编码的GPI基蛋白,对于DNA合成,细胞增殖和细胞内信号传递至关重要.
- 与正常组织相比,FRα在各种癌细胞中显著过度表达,包括卵巢癌,非小细胞肺癌 (NSCLC) 和结肠癌.
研究的目的:
- 审查叶酸受体α (FRα) 作为治疗点和瘤学中的生物标记物的作用.
- 突出FRα在开发新型癌症治疗和诊断工具中的应用.
主要方法:
- 对癌症中叶酸受体α (FRα) 的研究的文献综述.
- 分析FRα在瘤发生中的作用及其在不同癌症类型中的表达模式.
- 检查针对FRα的当前和新兴治疗策略.
主要成果:
- 由于其癌症特异性的过度表达,FRα是瘤治疗的验证目标.
- 在抗体药物合物,小分子药物合物和CAR-T细胞疗法中使用FRα.
- FRα作为预后标志物和化学疗法耐药性的预测指标.
结论:
- 在精准医学中,FRα是癌症治疗和诊断的关键目标.
- 向FRα为开发有效的瘤疗法提供了一个有希望的途径.
- 识别FRα对于个性化癌症护理策略至关重要.
更多相关视频
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
01:27Tumor Immunotherapy
527
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
527
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:38Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K